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ABSTRACT 
 
Background and Objectives: The outcome of Leishmania infection mainly depends upon the Leishmania species which 
causes the disease and the generation of the type of host immune response, the healing process and protection in leishman-
iasis depends upon induction of Th1 response. In this study, the Th1/Th2 cytokine profile in cutaneous leishmaniasis (CL) 
is evaluated.
Materials and Methods: This study was carried out in leishmaniasis clinic of CRTSDL, TUMS, during March 2018 to 
March 2019. Peripheral blood mononuclear cells (PBMC) of volunteers with active healing and non-healing lesion (s) of 
cutaneous leishmaniasis (CL), volunteers with and without history of CL were cultured and stimulated with Soluble Leish-
mania antigen (SLA). The supernatants were collected and the levels of IFN-γ, IL-5 and IL-10 were titrated using ELISA 
method. 
Results: The results showed a significantly higher levels of IFN-γ in volunteers with active CL healing form (p<0.005), 
history of CL (p<0.005) than healthy volunteers. A significantly (p<0.005) higher level of IFN-γ was seen in volunteers with 
active healing form of lesion than non-healing form. There was a significantly (p<0.005) higher level of IL-10 in volunteers 
with a history of non-healing form and active non-healing form of CL. There was no significant difference in IL-5 production 
in PBMC of different groups. 
Conclusion: IFN-γ production starts at early stage of cutaneous leishmaniasis and enhance during course of lesion healing, 
IFN-γ level is significantly higher in all patients compared to healthy volunteers, IFN-γ is significantly higher in patients with 
healing form than non-healing form of lesion.
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Leishmaniasis is endemic in 102 countries and is 
the main health problem in some of the endemic re-
gions which are the poorest areas of the world. Leish-
maniasis is endemic in 14 of 22 WHO/EMRO region 
countries. Annually, 200,000-400,000 people devel-
